Drug developers are under pressure to expand diversity, equity, and inclusion (DEI) in their clinical trials in order to better test the safety and efficacy of potential treatments on wider populations.
However, sponsors and sites continue to face challenges as they seek to recruit clinical trial participants that represent the diversity of the people affected by each disease or condition being studied.
This webinar targets professionals across the clinical trial ecosystem with best practices learned from executives representing pharma, academia, policy makers, and regulators about taking collective action to drive DEI-focused improvements in clinical trials. You will learn about building trust within historically underrepresented racial and ethnic minority communities, making clinical trials inclusive by design, and fostering partnership to address DEI-related issues in an integrated and sustainable manner.
Rear Admiral Richardae Araojo
Associate Commissioner for Minority Health
Director of the Office of Minority Health and Health Equity
U.S. Food and Drug Administration
Monique Adams, PhD
Global Head, Diversity & Inclusion in Clinical Trials
FasterCures, a Center of the Milken Institute
Siham Mahgoub, MD
Medical Director, Center for Infectious Disease Management
Research and Assistant Professor of Medicine, Department of Medicine, Division of Infectious Diseases
Howard University College of Medicine
R’Kes Starling, RPh, MBA (Moderator)
Chief Executive Officer/President